vinflunine,docetaxel,erdafitinib,pembrolizumab
pierre fabre,merck,janssen
['bladder', 'urothelial', 'erdafitinib', 'thor study']
ready for:
phase 3 thor study: results of erdafitinib (erda) versus chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (muc) with select fibroblast growth factor receptor alterations (fgfralt). #bladder #cancer 
On the road! Medical Oncologist & Prof @AnkaraUni | GU cancer expert  🔬| Diversity & Equity 📢 Advocate 💫  🌍 #Oncology #GenitourinaryCancer